Suboxone is a medicine that helps people with opioid addiction. It has two main parts: buprenorphine and naloxone. Buprenorphine reduces withdrawal symptoms and cravings, while naloxone stops opioids from working.
If you’re breastfeeding and taking Suboxone, it’s essential to talk to your doctor.
Breastfeeding is great for both mom and baby, but there are concerns about how Suboxone might affect the baby through breast milk.
Suboxone, a combination of buprenorphine and naloxone, is commonly used for opioid use disorder (OUD) treatment. When considering breastfeeding while on Suboxone, several medical considerations and guidelines should be taken into account:
Medical Considerations:
Buprenorphine Levels in Breast Milk: Buprenorphine has low levels in breast milk and poor oral bioavailability in infants, making it generally safe for breastfeeding mothers. Studies have shown that the amount of buprenorphine ingested by an infant through breast milk is minimal and unlikely to cause significant effects.
Infant Monitoring: Despite the low levels, it is essential to monitor the infant for any signs of drowsiness, respiratory depression, adequate weight gain, and developmental milestones.
If the baby shows increased sleepiness, difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately.
Withdrawal Symptoms: If breastfeeding is stopped abruptly, infants should be observed for withdrawal signs. This is particularly important for mothers who received buprenorphine during pregnancy.
Guidelines:
Consult Healthcare Professionals: It is crucial to consult with healthcare professionals, including the prescribing doctor and the baby’s pediatrician, before and during breastfeeding while on Suboxone. They can provide personalized guidance and monitor both the mother and the baby for any potential issues.
Stable Use: Women who are stable on buprenorphine for OUD treatment should be encouraged to breastfeed unless there is another contraindication, such as the use of street drugs.
Behavioral Treatments: Continuing with behavioral treatments and support groups can help maintain stability and reduce the risk of relapse while breastfeeding.
Potential Risks:
Drowsiness and Respiratory Depression: Although rare, there is a potential risk of drowsiness and respiratory depression in the infant due to the small amount of buprenorphine that passes through breast milk.
Withdrawal Symptoms: Abrupt cessation of breastfeeding can lead to withdrawal symptoms in the infant.
Potential Benefits:
Nutritional and Immunological Benefits: Breastfeeding provides essential nutrients and antibodies that support the baby’s growth, development, and immune system.
Maternal Health Benefits: Breastfeeding can help mothers recover from childbirth, reduce the risk of certain diseases, and promote bonding with the baby.
Stability and Focus: Buprenorphine helps manage drug cravings and withdrawal symptoms, allowing the mother to focus on caring for her baby.
Consulting with healthcare professionals is paramount to ensure the safety and well-being of both the mother and the baby while breastfeeding on Suboxone.
They can provide tailored advice and closely monitor any potential risks or benefits.
:
:
:
1www.drugs.com2www.confidanthealth.com3www.bicyclehealth.com
Breastfeeding is generally safe for mothers taking Suboxone, but it’s essential to consult with healthcare professionals before and during breastfeeding.
Buprenorphine, the active ingredient in Suboxone, has low levels in breast milk and poor oral bioavailability in infants, making it unlikely to cause significant effects. However, monitoring the infant for signs of drowsiness, respiratory depression, adequate weight gain, and developmental milestones is crucial.
If breastfeeding is stopped abruptly, infants may experience withdrawal symptoms, especially if their mother received buprenorphine during pregnancy. It’s essential to consult with healthcare professionals, including the prescribing doctor and the baby’s pediatrician, for personalized guidance and monitoring.
Continuing with behavioral treatments and support groups can help maintain stability and reduce the risk of relapse while breastfeeding. While there are potential risks associated with breastfeeding on Suboxone, such as drowsiness and respiratory depression in the infant, the benefits of breastfeeding, including nutritional and immunological benefits for the baby and maternal health benefits for the mother, outweigh these risks.
Ultimately, making informed decisions about breastfeeding while on Suboxone requires careful consideration of individual circumstances and consultation with healthcare professionals. By seeking professional medical advice, mothers can ensure the safety and well-being of both themselves and their babies.